Patent · US Active

Sodium channel protein type III α-subunit splice variant

US8663936B2 · kind B2 · utility

0Cited by

45References

5Claims

0Family size

Assignee

Vertex Pharmaceuticals Incorporated · US

Inventors

Kenneth McCormack · Oceanside, US
Christopher Dinesh Raj · San Diego, US

Key dates

Filing date	Jul 25, 2012
Grant date	Mar 4, 2014
Priority date	—
Expiry date	Jul 25, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/00
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention is directed to a splice variant of a human sodium channel alpha subunit and methods and compositions for making and using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.